Correlation Between RenovoRx and Neurocrine Biosciences

Can any of the company-specific risk be diversified away by investing in both RenovoRx and Neurocrine Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RenovoRx and Neurocrine Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between RenovoRx and Neurocrine Biosciences, you can compare the effects of market volatilities on RenovoRx and Neurocrine Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RenovoRx with a short position of Neurocrine Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of RenovoRx and Neurocrine Biosciences.

Diversification Opportunities for RenovoRx and Neurocrine Biosciences

0.41

Correlation Coefficient

RenovoRx  Neurocrine Biosciences

Very weak diversification

The 3 months correlation between RenovoRx and Neurocrine is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding RenovoRx and Neurocrine Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurocrine Biosciences and RenovoRx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RenovoRx are associated (or correlated) with Neurocrine Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurocrine Biosciences has no effect on the direction of RenovoRx i.e., RenovoRx and Neurocrine Biosciences go up and down completely randomly.

Pair Corralation between RenovoRx and Neurocrine Biosciences

Given the investment horizon of 90 days RenovoRx is expected to generate 1.67 times more return on investment than Neurocrine Biosciences. However, RenovoRx is 1.67 times more volatile than Neurocrine Biosciences. It trades about 0.08 of its potential returns per unit of risk. Neurocrine Biosciences is currently generating about -0.27 per unit of risk. If you would invest  96.00  in RenovoRx on June 26, 2024 and sell it today you would earn a total of  7.00  from holding RenovoRx or generate 7.29% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

RenovoRx  vs.  Neurocrine Biosciences

RenovoRx

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days RenovoRx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, RenovoRx is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Neurocrine Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Neurocrine Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's forward indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with RenovoRx and Neurocrine Biosciences

The main advantage of trading using opposite RenovoRx and Neurocrine Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RenovoRx position performs unexpectedly, Neurocrine Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurocrine Biosciences will offset losses from the drop in Neurocrine Biosciences' long position.

The idea behind RenovoRx and Neurocrine Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.